Loading clinical trials...
Loading clinical trials...
As a new dual receptor (integrin αvβ3 and FAP) targeting PET radiotracer, 68Ga-FAPI-RGD is promising as an excellent imaging agent applicable to various cancers. In this research, we investigate the s...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The First Affiliated Hospital of Xiamen University
NCT07433283 · Tumor, Solid, Lung Cancer, and more
NCT07348042 · Tumor, Solid
NCT06116032 · Cancer, Tumor, Solid, and more
NCT06478251 · Tumor, Solid
NCT03454035 · Tumor, Solid, Pancreatic Cancer, and more
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions